These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36399266)

  • 1. Three-Dimensional Imaging of Fibrinogen and Neurovascular Alterations in Alzheimer's Disease.
    Merlini M; Sozmen EG; Subramanian KS; Nana AL; Seeley WW; Akassoglou K
    Methods Mol Biol; 2023; 2561():87-101. PubMed ID: 36399266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.
    Merlini M; Rafalski VA; Rios Coronado PE; Gill TM; Ellisman M; Muthukumar G; Subramanian KS; Ryu JK; Syme CA; Davalos D; Seeley WW; Mucke L; Nelson RB; Akassoglou K
    Neuron; 2019 Mar; 101(6):1099-1108.e6. PubMed ID: 30737131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.
    McAleese KE; Graham S; Dey M; Walker L; Erskine D; Johnson M; Johnston E; Thomas AJ; McKeith IG; DeCarli C; Attems J
    Brain Pathol; 2019 May; 29(3):414-424. PubMed ID: 30485582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Dimensional Study of Alzheimer's Disease Hallmarks Using the iDISCO Clearing Method.
    Liebmann T; Renier N; Bettayeb K; Greengard P; Tessier-Lavigne M; Flajolet M
    Cell Rep; 2016 Jul; 16(4):1138-1152. PubMed ID: 27425620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen and altered hemostasis in Alzheimer's disease.
    Cortes-Canteli M; Zamolodchikov D; Ahn HJ; Strickland S; Norris EH
    J Alzheimers Dis; 2012; 32(3):599-608. PubMed ID: 22869464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
    Chung YC; Kruyer A; Yao Y; Feierman E; Richards A; Strickland S; Norris EH
    J Thromb Haemost; 2016 Jul; 14(7):1442-52. PubMed ID: 27090576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
    Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
    Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains.
    Bian Z; Yamashita T; Shi X; Feng T; Yu H; Hu X; Hu X; Bian Y; Sun H; Tadokoro K; Takemoto M; Omote Y; Morihara R; Abe K
    Brain Res; 2021 Sep; 1767():147569. PubMed ID: 34197775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration.
    Cortes-Canteli M; Mattei L; Richards AT; Norris EH; Strickland S
    Neurobiol Aging; 2015 Feb; 36(2):608-17. PubMed ID: 25475538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Leaky Blood-Brain Barrier to Fibrinogen Contributes to Oxidative Damage in Alzheimer's Disease.
    McLarnon JG
    Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer's Disease Brains.
    Soto-Rojas LO; Campa-Córdoba BB; Harrington CR; Salas-Casas A; Hernandes-Alejandro M; Villanueva-Fierro I; Bravo-Muñoz M; Garcés-Ramírez L; De La Cruz-López F; Ontiveros-Torres MÁ; Gevorkian G; Pacheco-Herrero M; Luna-Muñoz J
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lecanemab blocks the effects of the Aβ/fibrinogen complex on blood clots and synapse toxicity in organotypic culture.
    Singh PK; Simões-Pires EN; Chen ZL; Torrente D; Calvano M; Sharma A; Strickland S; Norris EH
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2314450121. PubMed ID: 38621133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.
    Ryu JK; McLarnon JG
    J Cell Mol Med; 2009 Sep; 13(9A):2911-25. PubMed ID: 18657226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.
    Hultman K; Strickland S; Norris EH
    J Cereb Blood Flow Metab; 2013 Aug; 33(8):1251-8. PubMed ID: 23652625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.
    Ahn HJ; Glickman JF; Poon KL; Zamolodchikov D; Jno-Charles OC; Norris EH; Strickland S
    J Exp Med; 2014 Jun; 211(6):1049-62. PubMed ID: 24821909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
    Sagare AP; Bell RD; Zlokovic BV
    J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.